A surgical orthotopic approach for studying the invasive progression of human bladder cancer
The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the molecular basis is poorly understood, partly because of the lack of uncomplicated and reliable models that recapitulate the biology of locally inv...
Saved in:
Published in | Nature protocols Vol. 14; no. 3; pp. 738 - 755 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.03.2019
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the molecular basis is poorly understood, partly because of the lack of uncomplicated and reliable models that recapitulate the biology of locally invasive disease. We developed a surgical grafting technique, characterized by a simple, rapid, reproducible and high-efficiency approach, to recapitulate the pathobiological events of human bladder cancer invasion in mice. This technique consists of a small laparotomy and direct implantation of human cancer cells into the bladder lumen. Unlike other protocols, it does not require debriding of the urothelial lining, injection into the bladder wall, specialized imaging equipment, bladder catheterization or costly surgical equipment. With minimal practice, the procedure can be executed in <10 min. Tumors develop with a high take rate, and most cell lines exhibit local invasion within 4 weeks of implantation.
A small laparotomy is carried out, and human cancer cells are implanted into the mouse bladder lumen. This reproduces the pathobiological events of human bladder cancer invasion in mice. |
---|---|
AbstractList | The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the molecular basis is poorly understood, partly because of the lack of uncomplicated and reliable models that recapitulate the biology of locally invasive disease. We developed a surgical grafting technique, characterized by a simple, rapid, reproducible and high-efficiency approach, to recapitulate the pathobiological events of human bladder cancer invasion in mice. This technique consists of a small laparotomy and direct implantation of human cancer cells into the bladder lumen. Unlike other protocols, it does not require debriding of the urothelial lining, injection into the bladder wall, specialized imaging equipment, bladder catheterization or costly surgical equipment. With minimal practice, the procedure can be executed in <10 min. Tumors develop with a high take rate, and most cell lines exhibit local invasion within 4 weeks of implantation.
A small laparotomy is carried out, and human cancer cells are implanted into the mouse bladder lumen. This reproduces the pathobiological events of human bladder cancer invasion in mice. The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the molecular basis is poorly understood, partly because of the lack of uncomplicated and reliable models that recapitulate the biology of locally invasive disease. We developed a surgical grafting technique, characterized by a simple, rapid, reproducible and high-efficiency approach, to recapitulate the pathobiological events of human bladder cancer invasion in mice. This technique consists of a small laparotomy and direct implantation of human cancer cells into the bladder lumen. Unlike other protocols, it does not require debriding of the urothelial lining, injection into the bladder wall, specialized imaging equipment, bladder catheterization or costly surgical equipment. With minimal practice, the procedure can be executed in <10 min. Tumors develop with a high take rate, and most cell lines exhibit local invasion within 4 weeks of implantation.The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the molecular basis is poorly understood, partly because of the lack of uncomplicated and reliable models that recapitulate the biology of locally invasive disease. We developed a surgical grafting technique, characterized by a simple, rapid, reproducible and high-efficiency approach, to recapitulate the pathobiological events of human bladder cancer invasion in mice. This technique consists of a small laparotomy and direct implantation of human cancer cells into the bladder lumen. Unlike other protocols, it does not require debriding of the urothelial lining, injection into the bladder wall, specialized imaging equipment, bladder catheterization or costly surgical equipment. With minimal practice, the procedure can be executed in <10 min. Tumors develop with a high take rate, and most cell lines exhibit local invasion within 4 weeks of implantation. The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the molecular basis is poorly understood, partly because of the lack of uncomplicated and reliable models that recapitulate the biology of locally invasive disease. We developed a surgical grafting technique, characterized by a simple, rapid, reproducible and high-efficiency approach, to recapitulate the pathobiological events of human bladder cancer invasion in mice. This technique consists of a small laparotomy and direct implantation of human cancer cells into the bladder lumen. Unlike other protocols, it does not require debriding of the urothelial lining, injection into the bladder wall, specialized imaging equipment, bladder catheterization or costly surgical equipment. With minimal practice, the procedure can be executed in <10 min. Tumors develop with a high take rate, and most cell lines exhibit local invasion within 4 weeks of implantation. A small laparotomy is carried out, and human cancer cells are implanted into the mouse bladder lumen. This reproduces the pathobiological events of human bladder cancer invasion in mice. The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the molecular basis is poorly understood, partly because of the lack of uncomplicated and reliable models that recapitulate the biology of locally invasive disease. We developed a surgical grafting technique, characterized by a simple, rapid, reproducible and high-efficiency approach, to recapitulate the pathobiological events of human bladder cancer invasion in mice. This technique consists of a small laparotomy and direct implantation of human cancer cells into the bladder lumen. Unlike other protocols, it does not require debriding of the urothelial lining, injection into the bladder wall, specialized imaging equipment, bladder catheterization or costly surgical equipment. With minimal practice, the procedure can be executed in <10 min. Tumors develop with a high take rate, and most cell lines exhibit local invasion within 4 weeks of implantation. |
Audience | Academic |
Author | Briggs, Hannah L. Palmbos, Phillip L. Chou, Andrew El-Sawy, Layla Udager, Aaron M. Broses, Luke J. Keller, Evan T. Lorenzatti Hiles, Guadalupe Day, Mark L. Day, Kathleen C. Abel, Ethan V. Liebert, Monica Han, Amy L. Cates, Angelica L. Emamdjomeh, Amir |
Author_xml | – sequence: 1 givenname: Guadalupe orcidid: 0000-0002-8423-3279 surname: Lorenzatti Hiles fullname: Lorenzatti Hiles, Guadalupe organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center, Division of Head and Neck Surgery, Department of Otolaryngology, University of Michigan – sequence: 2 givenname: Angelica L. surname: Cates fullname: Cates, Angelica L. organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center, College of Veterinary Medicine, Michigan State University – sequence: 3 givenname: Layla surname: El-Sawy fullname: El-Sawy, Layla organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center, European Egyptian Pharmaceutical Industries – sequence: 4 givenname: Kathleen C. surname: Day fullname: Day, Kathleen C. organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center – sequence: 5 givenname: Luke J. surname: Broses fullname: Broses, Luke J. organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center – sequence: 6 givenname: Amy L. surname: Han fullname: Han, Amy L. organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center, Department of Pathology, University of Michigan, School of Medicine, Anschutz Medical Campus, University of Colorado Denver – sequence: 7 givenname: Hannah L. orcidid: 0000-0003-0686-4523 surname: Briggs fullname: Briggs, Hannah L. organization: Division of Urologic Oncology, Department of Urology, University of Michigan, Division of Head and Neck Surgery, Department of Otolaryngology, University of Michigan – sequence: 8 givenname: Amir surname: Emamdjomeh fullname: Emamdjomeh, Amir organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center, College of Pharmacy and Health Sciences, Wayne State University – sequence: 9 givenname: Andrew surname: Chou fullname: Chou, Andrew organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center, College of Medicine, University of Cincinnati – sequence: 10 givenname: Ethan V. surname: Abel fullname: Abel, Ethan V. organization: University of Michigan Rogel Cancer Center, Department of Molecular and Integrative Physiology, University of Michigan – sequence: 11 givenname: Monica surname: Liebert fullname: Liebert, Monica organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center – sequence: 12 givenname: Phillip L. surname: Palmbos fullname: Palmbos, Phillip L. organization: University of Michigan Rogel Cancer Center, Division of Haematology and Oncology, Department of Internal Medicine, University of Michigan – sequence: 13 givenname: Aaron M. surname: Udager fullname: Udager, Aaron M. organization: Department of Pathology, University of Michigan – sequence: 14 givenname: Evan T. orcidid: 0000-0002-7592-7535 surname: Keller fullname: Keller, Evan T. email: etkeller@umich.edu organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center, Department of Pathology, University of Michigan – sequence: 15 givenname: Mark L. orcidid: 0000-0001-7774-2326 surname: Day fullname: Day, Mark L. email: mday@umich.edu organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30683938$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kl1rHCEUhoeS0ny0P6A3RehNezGpOqOOl0voRyBQ6MddQdQ5zhpmdatOaP593W7asKEtIoo87_HlnPe0OQoxQNM8J_ic4G54k3vCJG8xGeomtB0eNSdEMNxSIeXRr3vfUjLI4-Y052uMe9Fx8aQ57jAfOtkNJ823FcpLmrzVM4qprGOJW2-R3m5T1HaNXEwol2W89WFCZQ3Ihxud_Q2gCkwJcvYxoOjQetnogMysxxESsjpYSE-bx07PGZ7dnWfN13dvv1x8aK8-vr-8WF21thoqbScMlf0IbBwcN44DNZIyJnqAkXFjGJcYLHXWSWM6Sam2HGRnCMWaWOK6s-bVvm719H2BXNTGZwvzrAPEJStKhOyxlJhV9OUD9DouKVR3lRoEpoRgck9Negblg4slabsrqlZM8Nr2gfFKnf-FqmuEjbd1VM7X9wPB6wNBZQr8KJNeclaXnz8dsi_ujC5mA6PaJr_R6Vb9Hl0FyB6wKeacwP1BCFa7eKh9PFSNh9rFQ-004oHG-qJLHWF17uf_KulemesvYYJ037d_i34CQyzMFw |
CitedBy_id | crossref_primary_10_1002_ame2_12293 crossref_primary_10_1039_C9LC01006H crossref_primary_10_3390_cancers12020439 crossref_primary_10_1016_j_prp_2023_154724 crossref_primary_10_1042_BSR20193484 crossref_primary_10_2139_ssrn_4103916 crossref_primary_10_1038_s41585_024_00885_9 crossref_primary_10_18632_aging_203818 crossref_primary_10_3389_fphar_2022_1050774 crossref_primary_10_1016_j_hoc_2021_02_007 crossref_primary_10_1111_jcmm_18225 crossref_primary_10_1080_21655979_2021_2008738 crossref_primary_10_1016_j_ab_2022_114805 crossref_primary_10_1109_ACCESS_2021_3098510 crossref_primary_10_1158_0008_5472_CAN_22_2485 crossref_primary_10_1038_s41596_019_0194_y crossref_primary_10_1158_0008_5472_CAN_22_2233 crossref_primary_10_1016_j_celrep_2023_113067 crossref_primary_10_1111_php_14048 crossref_primary_10_1002_advs_202302377 crossref_primary_10_4103_azmj_azmj_30_22 |
Cites_doi | 10.1111/bju.12601 10.7554/eLife.33947 10.1371/journal.pone.0059536 10.1016/j.eururo.2005.12.031 10.1158/1535-7163.MCT-12-1150 10.1242/dmm.008888 10.1038/nrc3858 10.4161/cbt.5.4.2509 10.1038/sj.cgt.7700261 10.1200/JCO.2012.46.5740 10.1186/s12885-017-3778-3 10.1158/0008-5472.CAN-16-1656 10.1016/S0022-5347(17)45139-1 10.1098/rsob.170006 10.1111/j.1464-410X.2009.08577.x 10.1038/onc.2017.149 10.3322/caac.21442 10.1016/S0022-5347(01)66923-4 10.1038/s41419-018-0325-3 10.3322/caac.21262 10.1158/1078-0432.CCR-15-2360 10.2165/00003495-200969090-00003 10.1016/S0022-5347(17)35536-2 10.1111/j.1464-410X.2009.09166.x 10.1016/S0022-5347(05)00323-X 10.1126/science.1203486 10.1007/978-1-4939-7234-0_15 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Nature America, Inc. 2019 COPYRIGHT 2019 Nature Publishing Group 2019© The Author(s), under exclusive licence to Springer Nature America, Inc. 2019 |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature America, Inc. 2019 – notice: COPYRIGHT 2019 Nature Publishing Group – notice: 2019© The Author(s), under exclusive licence to Springer Nature America, Inc. 2019 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7QG 7T5 7T7 7TM 7X7 7XB 88E 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ATCPS AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P P64 PATMY PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PYCSY RC3 7X8 |
DOI | 10.1038/s41596-018-0112-8 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest One Sustainability ProQuest Central UK/Ireland Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Biotechnology and BioEngineering Abstracts Environmental Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Environmental Science Collection Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database Engineering Research Database ProQuest One Academic ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts ProQuest SciTech Collection ProQuest Medical Library Animal Behavior Abstracts Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest Central Student MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1750-2799 |
EndPage | 755 |
ExternalDocumentID | A576415856 30683938 10_1038_s41596_018_0112_8 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA154252 – fundername: NCI NIH HHS grantid: K08 CA201335 – fundername: NCI NIH HHS grantid: P30 CA046592 – fundername: NCATS NIH HHS grantid: UL1 TR002240 |
GroupedDBID | --- 0R~ 123 29M 39C 3TQ 3V. 4.4 53G 5BI 5M7 70F 7X7 7XC 88E 8FE 8FH 8FI 8FJ AAEEF AARCD AAWYQ AAYZH AAZLF ABAWZ ABJNI ABLJU ABUWG ACGFO ACGFS ACMJI ACPRK ADBBV ADFRT AENEX AEUYN AFBBN AFKRA AFRAH AFSHS AGAYW AHBCP AHMBA AHSBF AIBTJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH ARMCB ASPBG ATCPS ATWCN AVWKF AXYYD AZFZN BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF DB5 DU5 EBS EE. EJD EMOBN F5P FEDTE FSGXE FYUFA FZEXT HCIFZ HMCUK HVGLF HZ~ IAO IGS IHR INH INR ISR ITC LGEZI LK8 LOTEE M1P M7P NADUK NNMJJ NXXTH O9- ODYON P2P PATMY PQQKQ PROAC PSQYO PYCSY RNT RNTTT SHXYY SIXXV SNYQT SOJ SV3 TAOOD TBHMF TDRGL TSG UKHRP AAYXX ACMFV AFANA ATHPR CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NFIDA NPM PJZUB PPXIY PQGLB PMFND 7QG 7T5 7T7 7TM 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 |
ID | FETCH-LOGICAL-c473t-37b294de5d8f6bf6e2b925574eed56bb5690ec2fcf9bb3922ac6e93b120a1c1f3 |
IEDL.DBID | 7X7 |
ISSN | 1754-2189 1750-2799 |
IngestDate | Thu Jul 10 18:19:15 EDT 2025 Fri Jul 25 09:10:52 EDT 2025 Tue Jun 17 21:08:04 EDT 2025 Tue Jun 10 20:23:07 EDT 2025 Fri Jun 27 04:51:16 EDT 2025 Mon Jul 21 05:36:03 EDT 2025 Thu Apr 24 23:02:30 EDT 2025 Tue Jul 01 00:19:38 EDT 2025 Fri Feb 21 02:37:37 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c473t-37b294de5d8f6bf6e2b925574eed56bb5690ec2fcf9bb3922ac6e93b120a1c1f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-0686-4523 0000-0002-8423-3279 0000-0001-7774-2326 0000-0002-7592-7535 |
PMID | 30683938 |
PQID | 2187021101 |
PQPubID | 536306 |
PageCount | 18 |
ParticipantIDs | proquest_miscellaneous_2179409905 proquest_journals_2187021101 gale_infotracmisc_A576415856 gale_infotracacademiconefile_A576415856 gale_incontextgauss_ISR_A576415856 pubmed_primary_30683938 crossref_primary_10_1038_s41596_018_0112_8 crossref_citationtrail_10_1038_s41596_018_0112_8 springer_journals_10_1038_s41596_018_0112_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-03-01 |
PublicationDateYYYYMMDD | 2019-03-01 |
PublicationDate_xml | – month: 03 year: 2019 text: 2019-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationSubtitle | Recipes for Researchers |
PublicationTitle | Nature protocols |
PublicationTitleAbbrev | Nat Protoc |
PublicationTitleAlternate | Nat Protoc |
PublicationYear | 2019 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Torre (CR2) 2015; 65 Kobayashi, Owczarek, McKiernan, Abate-Shen (CR24) 2015; 15 Siegel, Miller, Jemal (CR1) 2018; 68 Calì, Molon, Viola (CR22) 2017; 7 Chong (CR15) 2006; 5 Schreiber, Old, Smyth (CR23) 2011; 331 Grossman, Wedemeyer, Ren, Wilson, Cox (CR25) 1986; 136 Iyer (CR8) 2013; 31 CR10 Dinney (CR12) 1995; 154 Han (CR11) 2017; 36 Smith (CR6) 2014; 114 Hayashi (CR20) 2016; 22 Gust (CR19) 2013; 12 Brunocilla, Pernetti, Martorana (CR5) 2011; 31 Sabichi (CR27) 2006; 175 Abel (CR28) 2018; 7 Yang (CR17) 2012; 9 Bolenz (CR4) 2010; 106 Huebner (CR14) 2017; 17 Agarwal, Hussain (CR3) 2009; 69 Hu (CR21) 2018; 9 Watanabe (CR16) 2000; 7 Ahmad, Sansom, Leung (CR18) 2012; 5 Jäger (CR13) 2013; 8 Sylvester (CR7) 2006; 49 Chan, Patel, Heston, Larchian (CR9) 2009; 104 Shinohara, Liebert, Wedemeyer, Chang, Grossman (CR26) 1993; 150 Day (CR29) 2017; 77 C Bolenz (112_CR4) 2010; 106 AL Han (112_CR11) 2017; 36 112_CR10 CP Dinney (112_CR12) 1995; 154 RD Schreiber (112_CR23) 2011; 331 RL Siegel (112_CR1) 2018; 68 W Jäger (112_CR13) 2013; 8 AB Smith (112_CR6) 2014; 114 I Ahmad (112_CR18) 2012; 5 G Iyer (112_CR8) 2013; 31 L Chong (112_CR15) 2006; 5 C Hu (112_CR21) 2018; 9 T Hayashi (112_CR20) 2016; 22 RJ Sylvester (112_CR7) 2006; 49 B Calì (112_CR22) 2017; 7 E Brunocilla (112_CR5) 2011; 31 N Agarwal (112_CR3) 2009; 69 KC Day (112_CR29) 2017; 77 T Watanabe (112_CR16) 2000; 7 HB Grossman (112_CR25) 1986; 136 D Huebner (112_CR14) 2017; 17 E Chan (112_CR9) 2009; 104 XH Yang (112_CR17) 2012; 9 KM Gust (112_CR19) 2013; 12 N Shinohara (112_CR26) 1993; 150 EV Abel (112_CR28) 2018; 7 LA Torre (112_CR2) 2015; 65 T Kobayashi (112_CR24) 2015; 15 A Sabichi (112_CR27) 2006; 175 |
References_xml | – volume: 114 start-page: 719 year: 2014 end-page: 726 ident: CR6 article-title: Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base publication-title: BJU Int. doi: 10.1111/bju.12601 – volume: 7 start-page: e33947 year: 2018 ident: CR28 article-title: HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties publication-title: Elife doi: 10.7554/eLife.33947 – volume: 8 start-page: e59536 year: 2013 ident: CR13 article-title: Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach publication-title: PLoS ONE doi: 10.1371/journal.pone.0059536 – volume: 49 start-page: 466 year: 2006 end-page: 477 ident: CR7 article-title: Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials publication-title: Eur. Urol. doi: 10.1016/j.eururo.2005.12.031 – volume: 12 start-page: 1245 year: 2013 end-page: 1254 ident: CR19 article-title: Fibroblast growth factor receptor 3 is a rational therapeutic target in bladder cancer publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-12-1150 – volume: 5 start-page: 323 year: 2012 end-page: 332 ident: CR18 article-title: Exploring molecular genetics of bladder cancer: lessons learned from mouse models publication-title: Dis. Model. Mech. doi: 10.1242/dmm.008888 – volume: 15 start-page: 42 year: 2015 end-page: 54 ident: CR24 article-title: Modelling bladder cancer in mice: opportunities and challenges publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3858 – ident: CR10 – volume: 5 start-page: 394 year: 2006 end-page: 398 ident: CR15 article-title: Characterization of a novel transplantable orthotopic murine xenograft model of a human bladder transitional cell tumor (BIU-87) publication-title: Cancer Biol. Ther. doi: 10.4161/cbt.5.4.2509 – volume: 7 start-page: 1575 year: 2000 end-page: 1580 ident: CR16 article-title: An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies publication-title: Cancer Gene Ther. doi: 10.1038/sj.cgt.7700261 – volume: 31 start-page: 3133 year: 2013 end-page: 3140 ident: CR8 article-title: Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2012.46.5740 – volume: 17 year: 2017 ident: CR14 article-title: An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment publication-title: BMC Cancer doi: 10.1186/s12885-017-3778-3 – volume: 77 start-page: 74 year: 2017 end-page: 85 ident: CR29 article-title: HER2 and EGFR overexpression support metastatic progression of prostate cancer to bone publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-16-1656 – volume: 136 start-page: 953 year: 1986 end-page: 959 ident: CR25 article-title: Improved growth of human urothelial carcinoma cell cultures publication-title: J. Urol. doi: 10.1016/S0022-5347(17)45139-1 – volume: 31 start-page: 3503 year: 2011 end-page: 3506 ident: CR5 article-title: The prognostic role of lymphovascular invasion in urothelial-cell carcinoma of upper and lower urinary tract publication-title: Anticancer Res. – volume: 7 start-page: 170006 year: 2017 ident: CR22 article-title: Tuning cancer fate: the unremitting role of host immunity publication-title: Open Biol. doi: 10.1098/rsob.170006 – volume: 104 start-page: 1286 year: 2009 end-page: 1291 ident: CR9 article-title: Mouse orthotopic models for bladder cancer research publication-title: BJU Int. doi: 10.1111/j.1464-410X.2009.08577.x – volume: 36 start-page: 5243 year: 2017 end-page: 5251 ident: CR11 article-title: Fibulin-3 promotes muscle-invasive bladder cancer publication-title: Oncogene doi: 10.1038/onc.2017.149 – volume: 9 start-page: 261 year: 2012 end-page: 265 ident: CR17 article-title: A new method of establishing orthotopic bladder transplantable tumor in mice publication-title: Cancer Biol. Med. – volume: 68 start-page: 7 year: 2018 end-page: 30 ident: CR1 article-title: Cancer statistics, 2018 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21442 – volume: 154 start-page: 1532 year: 1995 end-page: 1538 ident: CR12 article-title: Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice publication-title: J. Urol. doi: 10.1016/S0022-5347(01)66923-4 – volume: 9 year: 2018 ident: CR21 article-title: Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer publication-title: Cell Death Dis. doi: 10.1038/s41419-018-0325-3 – volume: 65 start-page: 87 year: 2015 end-page: 108 ident: CR2 article-title: Global cancer statistics, 2012 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21262 – volume: 22 start-page: 2981 year: 2016 end-page: 2992 ident: CR20 article-title: Not all NOTCH is created equal: the oncogenic role of NOTCH2 in bladder cancer and its implications for targeted therapy publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-15-2360 – volume: 69 start-page: 1173 year: 2009 end-page: 1187 ident: CR3 article-title: Management of bladder cancer: current and emerging strategies publication-title: Drugs doi: 10.2165/00003495-200969090-00003 – volume: 150 start-page: 505 year: 1993 end-page: 509 ident: CR26 article-title: Evaluation of multiple drug resistance in human bladder cancer cell lines publication-title: J. Urol. doi: 10.1016/S0022-5347(17)35536-2 – volume: 106 start-page: 493 year: 2010 end-page: 499 ident: CR4 article-title: Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial publication-title: BJU Int. doi: 10.1111/j.1464-410X.2009.09166.x – volume: 175 start-page: 1133 year: 2006 end-page: 1137 ident: CR27 article-title: Characterization of a panel of cell lines derived from urothelial neoplasms: genetic alterations, growth in vivo and the relationship of adenoviral mediated gene transfer to coxsackie adenovirus receptor expression publication-title: J. Urol. doi: 10.1016/S0022-5347(05)00323-X – volume: 331 start-page: 1565 year: 2011 end-page: 1570 ident: CR23 article-title: Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion publication-title: Science doi: 10.1126/science.1203486 – volume: 5 start-page: 394 year: 2006 ident: 112_CR15 publication-title: Cancer Biol. Ther. doi: 10.4161/cbt.5.4.2509 – volume: 15 start-page: 42 year: 2015 ident: 112_CR24 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3858 – volume: 65 start-page: 87 year: 2015 ident: 112_CR2 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21262 – volume: 175 start-page: 1133 year: 2006 ident: 112_CR27 publication-title: J. Urol. doi: 10.1016/S0022-5347(05)00323-X – volume: 7 start-page: 170006 year: 2017 ident: 112_CR22 publication-title: Open Biol. doi: 10.1098/rsob.170006 – volume: 154 start-page: 1532 year: 1995 ident: 112_CR12 publication-title: J. Urol. doi: 10.1016/S0022-5347(01)66923-4 – volume: 69 start-page: 1173 year: 2009 ident: 112_CR3 publication-title: Drugs doi: 10.2165/00003495-200969090-00003 – volume: 136 start-page: 953 year: 1986 ident: 112_CR25 publication-title: J. Urol. doi: 10.1016/S0022-5347(17)45139-1 – ident: 112_CR10 doi: 10.1007/978-1-4939-7234-0_15 – volume: 331 start-page: 1565 year: 2011 ident: 112_CR23 publication-title: Science doi: 10.1126/science.1203486 – volume: 104 start-page: 1286 year: 2009 ident: 112_CR9 publication-title: BJU Int. doi: 10.1111/j.1464-410X.2009.08577.x – volume: 31 start-page: 3133 year: 2013 ident: 112_CR8 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2012.46.5740 – volume: 5 start-page: 323 year: 2012 ident: 112_CR18 publication-title: Dis. Model. Mech. doi: 10.1242/dmm.008888 – volume: 9 year: 2018 ident: 112_CR21 publication-title: Cell Death Dis. doi: 10.1038/s41419-018-0325-3 – volume: 7 start-page: e33947 year: 2018 ident: 112_CR28 publication-title: Elife doi: 10.7554/eLife.33947 – volume: 22 start-page: 2981 year: 2016 ident: 112_CR20 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-15-2360 – volume: 7 start-page: 1575 year: 2000 ident: 112_CR16 publication-title: Cancer Gene Ther. doi: 10.1038/sj.cgt.7700261 – volume: 8 start-page: e59536 year: 2013 ident: 112_CR13 publication-title: PLoS ONE doi: 10.1371/journal.pone.0059536 – volume: 31 start-page: 3503 year: 2011 ident: 112_CR5 publication-title: Anticancer Res. – volume: 77 start-page: 74 year: 2017 ident: 112_CR29 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-16-1656 – volume: 68 start-page: 7 year: 2018 ident: 112_CR1 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21442 – volume: 114 start-page: 719 year: 2014 ident: 112_CR6 publication-title: BJU Int. doi: 10.1111/bju.12601 – volume: 36 start-page: 5243 year: 2017 ident: 112_CR11 publication-title: Oncogene doi: 10.1038/onc.2017.149 – volume: 17 year: 2017 ident: 112_CR14 publication-title: BMC Cancer doi: 10.1186/s12885-017-3778-3 – volume: 9 start-page: 261 year: 2012 ident: 112_CR17 publication-title: Cancer Biol. Med. – volume: 49 start-page: 466 year: 2006 ident: 112_CR7 publication-title: Eur. Urol. doi: 10.1016/j.eururo.2005.12.031 – volume: 12 start-page: 1245 year: 2013 ident: 112_CR19 publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-12-1150 – volume: 150 start-page: 505 year: 1993 ident: 112_CR26 publication-title: J. Urol. doi: 10.1016/S0022-5347(17)35536-2 – volume: 106 start-page: 493 year: 2010 ident: 112_CR4 publication-title: BJU Int. doi: 10.1111/j.1464-410X.2009.09166.x |
SSID | ssj0047367 |
Score | 2.3959723 |
Snippet | The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the... |
SourceID | proquest gale pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 738 |
SubjectTerms | 631/1647/767/70 631/67/589/1336 Analytical Chemistry Animal models Animals Biological Techniques Biomedical and Life Sciences Bladder Bladder cancer Cancer Catheterization Computational Biology/Bioinformatics Development and progression Diagnosis Disease Models, Animal Disease Progression Humans Implantation Invasiveness Laparotomy Life Sciences Metastases Methods Mice, Inbred NOD Mice, SCID Microarrays Muscles Neoplasm Invasiveness Organic Chemistry Protocol Surgical equipment Tumors Urinary Bladder Neoplasms - pathology Urinary Bladder Neoplasms - surgery Urothelial cancer Xenograft Model Antitumor Assays - methods |
Title | A surgical orthotopic approach for studying the invasive progression of human bladder cancer |
URI | https://link.springer.com/article/10.1038/s41596-018-0112-8 https://www.ncbi.nlm.nih.gov/pubmed/30683938 https://www.proquest.com/docview/2187021101 https://www.proquest.com/docview/2179409905 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdby2AvZd9z2xVtDAYbprb1YftpJKOhGyyMboU8DISkSKNQ7DROCv3vdyfL6VJYn_zgk-zTx33ofroj5L1gwjnJdepMhadVvEo19zz1rs4LzypZOryN_H0qT8_5t5mYxQO3LsIqB5kYBPW8tXhGfgyqqMzQW8k_L65SrBqF0dVYQuMh2cXUZQjpKmcbh4uXLFSQBQ3JU2hfD1FNVh13oLgQfpsjlCsHobCll-5K53_U0514aVBDkydkL9qPdNRP-FPywDXPyKO-ouTNc_J7RLv1MkgzihGZdtUuLiwdModTMFFpyCgLnVOw_ehFc60RwU4DUKtP0kFbT0PtPmouUTAtqcW1sXxBzicnv76cprGAQmqB9xUID1PUfO7EvPLSeOkKU4MLUXJQjEIaI8A1drbw1tfGgKFUaCtdzUxeZDq3uWcvyU7TNu41odpJsNzA29LO8sxwYzUXML-syKUoTZaQbBg-ZWN2cSxycalClJtVqh9xBSOucMRVlZCPmyaLPrXGfcTvcE4UpqxoEBPzR6-7Tn39eaZG4DIBeSVkQj5EIt_Cx62OVwyABcxytUV5uEUJe8puvx6mXsU93anbFZiQt5vX2BJxao1r10gD8g1jjSIhr_ols-ENnDOwRhmw8mlYQ7ed_5fx_ft_5YA8BhOu7lFxh2RntVy7N2AmrcxR2AtHZHc0GY-n8ByfTH-c_QXZVw7a |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgheEN8UBhgEQmKKlsR2Ph4QKrCpZVuFxibtAcnYro0mTUlpWtD-Kf5G7vLR0Unsbc-5OPH5fPc73_kO4JXk0rlE6MCZjE6rRBZo4UXgXR7FnmdJ6ug28v44GR6Jz8fyeA3-dHdhKK2y04m1op6Uls7It9AUpSF5K9H76c-AukZRdLVrodGIxa47-40uW_Vu9AnX93Uc72wffhwGbVeBwIqUz3FHmTgXEycnmU-MT1xscsTVqUBrIRNjJPqLzsbe-twYRA-xtonLuYniUEc28hzHvQbrgqMr04P1D9vjLwed7scP1D1r0SaLAP847-KoPNuq0FRSwm9EyWMRqqEVS3jRHvxjEC9EaGvDt3MbbrWIlQ0aEbsDa664C9ebHpZn9-DbgFWLWa0_GcWAynk5PbGsq1XOEBSzuoYtDs4QbbKT4pemnHlWp4Y1ZUFY6VndLZCZU1KFM2ZJGmf34ehKmPsAekVZuEfAtEsQK6J_p50VoRHGaiFRongcJTI1YR_Cjn3KtvXMqa3Gqarj6jxTDccVclwRx1XWh7fLV6ZNMY_LiF_SmigqklFQFs4PvagqNfp6oAbopCF5JpM-vGmJfIkft7q91IBToLpaK5QbK5S4i-3q427pVatFKnUu8314sXxMb1JmXOHKBdGgRqXopuzDw0ZklnNDdxDxL8epbHYydD74fyf--PJfeQ43hof7e2pvNN59AjcRQOZNTt4G9OazhXuKIG1unrU7g8H3q96MfwGiT0tZ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1da9RAcKgVpS_it9GqqyiCEi7JfiR5EDmsR89qEbVwD4U1u7dbCiU5L3dK_5q_zpl8XL2CfevzTja7s_O5MzsD8EJy6ZwSRehMRrdVIgsL4UXoXR4nnmcqdfQa-fO-2j0QHydysgF_-rcwlFbZy8RGUE8rS3fkA1RFaUTeSjzwXVrEl53Ru9nPkDpIUaS1b6fRksieO_2N7lv9dryDZ_0ySUYfvr_fDbsOA6EVKV8gd5kkF1Mnp5lXxiuXmBxt7FSg5pDKGIm-o7OJtz43Bi2JpLDK5dzESVTENvYc570CV1MuY-KxdLJy9nD6pnstamcR4trzPqLKs0GNSpNSf2NKI4tRIK3pxPOa4R_VeC5W26jA0U240dmubNgS2y3YcOVtuNZ2szy9A4dDVi_njSRlFA2qFtXs2LK-ajlD85g11WxxcoZ2JzsufxWUPc-aJLG2QAirPGv6BjJzQkJxzizR5fwuHFwKau_BZlmV7gGwwim0GtHTK5wVkRHGFkIibfEkVjI1UQBRjz5tu8rm1GDjRDcRdp7pFuMaMa4J4zoL4PXqk1lb1uMi4Od0JprKZZREeEfFsq71-NtXPUR3DcEzqQJ41QH5Cn9ui-55A26BKmytQW6vQSI_2_Xh_uh1J09qfUb9ATxbDdOXlCNXumpJMChbKc4pA7jfksxqb-gYoiXMcStveho6m_y_G3948VKewnVkQf1pvL_3CLbQkszb5Lxt2FzMl-4xWmsL86RhCwY_LpsP_wKPC04p |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+surgical+orthotopic+approach+for+studying+the+invasive+progression+of+human+bladder+cancer&rft.jtitle=Nature+protocols&rft.au=Lorenzatti+Hiles+Guadalupe&rft.au=Cates%2C+Angelica+L&rft.au=El-Sawy%2C+Layla&rft.au=Day%2C+Kathleen+C&rft.date=2019-03-01&rft.pub=Nature+Publishing+Group&rft.issn=1754-2189&rft.eissn=1750-2799&rft.volume=14&rft.issue=3&rft.spage=738&rft.epage=755&rft_id=info:doi/10.1038%2Fs41596-018-0112-8&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1754-2189&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1754-2189&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1754-2189&client=summon |